Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015-2017): A multicentre prospective study

• Main Authors: Yuankai Shi (Author), Xin Zhang (Author), Gang Wu (Author), Jianping Xu (Author), Yong He (Author), Dong Wang (Author), Cheng Huang (Author), Mingwei Chen (Author), Ping Yu (Author), Yan Yu (Author), Wei Li (Author), Qi Li (Author), Xiaohua Hu (Author), Jinjing Xia (Author), Lilian Bu (Author), Angela Yin (Author), Yigong Zhou (Author)
• Format: Book
• Published: Elsevier, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: There are limited studies on treatment and survival analysis among patients with unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC) in routine practice in China. To address this gap, we conducted a prospective observational study in a cohort of patients treated at...